| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $167.8M | +51.7% |
| Cost of Revenue | $166.5M | +37.9% |
| R&D Expense | $29.4M | +36.4% |
| SG&A Expense | $55.3M | +112.8% |
| Operating Income | -$104.3M | -45.5% |
| Pre-tax Income | -$101.7M | -41.6% |
| Income Tax | -$5.4M | -4785.2% |
| Net Income | -$96.3M | -33.9% |
| EPS (Basic) | -$0.49 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $210.4M | -51.2% |
| Accounts Receivable | $62.4M | +37.3% |
| Inventory | $75.7M | +128.0% |
| Current Assets | $378.4M | -29.4% |
| Total Assets | $560.8M | -3.2% |
| Current Liabilities | $132.8M | +88.2% |
| Total Liabilities | $196.6M | +51.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.0M | -15.1% |
| Capital Expenditures | $1.1M | -24.3% |
| Investing Cash Flow | -$130.8M | -1295.4% |
| Financing Cash Flow | -$2.8M | -100.6% |
| Free Cash Flow | -$82.2M | -14.3% |
| +49.0% |
| EPS (Diluted) | -$0.49 | +49.0% |
| Stockholders' Equity |
| $364.2M |
| -19.0% |